XML 55 R42.htm IDEA: XBRL DOCUMENT v3.3.1.900
DISCONTINUED OPERATIONS (Narrative) (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2015
Sep. 30, 2015
Dec. 31, 2015
Dec. 31, 2014
Nov. 25, 2015
Sep. 08, 2015
Included in assets held for sale | Genetic Assays and Platforms and Patient Testing            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
(Loss) gain on sale of business     $ (224) $ 4,114    
Edge BioSystems, Inc | Genetic Assays And Platforms Business            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Consideration received on assets disposal           $ 2,100
(Loss) gain on sale of business     1,500      
Edge BioSystems, Inc | Included in assets held for sale | Genetic Assays And Platforms Business            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
(Loss) gain on sale of business   $ 1,500        
ADSTEC Corporation | Genetic Assays And Platforms Business            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Consideration received on assets disposal         $ 300  
(Loss) gain on sale of business     $ (1,700)      
ADSTEC Corporation | Included in assets held for sale | Genetic Assays And Platforms Business            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
(Loss) gain on sale of business $ (1,700)